Abstract:
Un aspect de l’invention concerne un procédé de préparation d’une composition dentifrice, se présentant sous la forme d’une pastille comestible à sucer ou à mâcher et comportant : - Un complexe enzymatique comprenant les composés suivants : o invertase, o gluco oxydase, o amyloglucosidase, o lactoperoxydase, o lactoferrine, - au moins un agent gélifiant, caractérisé en ce qu’il comporte : - une étape de chauffage dudit au moins un agent gélifiant à une température comprise entre 82 et 88°C, - une étape d’encapsulation du complexe enzymatique par incorporation ou par ionisation dudit complexe enzymatique dans ledit au moins un agent gélifiant lorsque la température dudit au moins un agent gélifiant est comprise entre 55 et 65°C.
Abstract:
The present invention relates generally to a method for extracting cannabis-derived proteins from cannabis plant material, including the preparation of samples of extracted cannabis-derived proteins for proteomic analysis and methods for analysing a cannabis plant proteome.
Abstract:
The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.
Abstract:
Compositions for the treatment and prevention of symptoms and disease conditions associated with oxidative and carbonyl stress, including advanced glycation end products (AGEs), and to methods using the compositions. In particular, the invention relates to compositions useful in the treatment of diabetic retinopathy and nephropathy, to compositions useful in the treatment of other retinal disorders including macular degeneration and cataracts.
Abstract:
The disclosure provides, in part, compositions comprising mature recombinant mature Complement Factor I (CFI) protein and methods of making and using those compositions.
Abstract:
This disclosure relates to methods and materials for treating functional dyspepsia (FD). Specifically, the disclosure provides a method for treating FD in a mammal, wherein said method comprising administering a composition comprising secretin, or a composition comprising neprilysin inhibitor, to a mammal identified as having FD, wherein a symptom of said FD is reduced. Further disclosed are symptoms of FD that can be treated.
Abstract:
The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.
Abstract:
The present disclosure provides compositions and methods for treating an infection by human metapneumovirus (hMPV). In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by hMPV.
Abstract:
This invention is attributed to the fields of biotechnology and biomedicine. The essence of this invention is to use enzymes extracted from Streptomyces gougerotii 101 in order to create multienzyme preparations with proteolytic, collagenasic, esterasic, amylolytic, lipasic, glucanasic, deoxyribunocleasic and lytic activities, and to employ them in the development of cosmetics, antibacterial preparations and preparations for wound care. Multienzyme biopreparation development technology is distinguishable by the fact that, as you change enzyme concentrations within, their application field changes too.